News

14
Dec

Genoskin in Japan to attend 42th Annual JSID meeting

GENOSKIN TO ATTEND 42TH ANNUAL JSID MEETING Genoskin is very pleased to attend the 42th Annual Meeting of the Japanese Society for Investigative Dermatology (JSID). The meeting will take place in Kochi city, Japan from December 15th to 17th, 2017. The mission of the Japanese Society for Investigative Dermatology (JSID) is to advance the position of dermatology in the interdisciplinary world

Read more

29
Sep

Genoskin launches psoriasis skin model at ESDR-meeting

Toulouse, France, September 29th, 2017 – Genoskin launches a new skin model to study skin inflammation. InflammaSkin® is a T cell-driven skin inflammation model with a psoriasis-like phenotype. The pharmacological validation of this psoriasis skin model will be presented at the 47th annual ESDR meeting 2017 (Poster 100) on September 27th to 30th, 2017. Don't hesitate to visit us in booth #9. Why immunocompetent skin
Read more
21
Sep

Study on indoor air pollution uses NativeSkin® model

New study on effects of indoor air pollution on human skin uses NativeSkin® models Indoor air pollution may alter human skin. A study that was recently published in Scientific Reports  shows that volatile organic compounds target the cellular mechanism that eliminates damaged proteins. The study uses Genoskin's NativeSkin® model to study the effects of indoor air pollution on human skin and
Read more
13
Sep

Genoskin kicks off fundraising campaign

Genoskin kicks off fundraising campaign at CCI FINDays The Genoskin team is now officially ready to launch its biggest fundraising campaign so far, which aims to finance our international expansion. Pascal Descargues, our CEO, is heading for Paris next week to attend the CCI FINDays, the first in a series of fundraising meetings. CCI FINDays is a French event designed to help small and start-up
Read more
29
Aug

Genoskin brings unique alternative to animal testing to the US

Skin biotech to set up Boston production unit that recycles excess human skin Toulouse, France, August 29, 2017 – Genoskin, a company that provides a cutting-edge alternative to animal testing by keeping donated human skin alive, today announces its expansion into North America. The biotech has established a representative office in Boston and plans to open a local production unit
Read more
12
Jul

Genoskin to attend ESDR 2017

GENOSKIN TO ATTEND 47TH ANNUAL ESDR MEETING 2017 Here at Genoskin, we’re pleased to announce our presence at the 47th Annual Meeting of the European Society for Dermatological Research (ESDR). The meeting will take place in Salzburg, Austria from September 27th to 30th, 2017. The ESDR aims to promote research in dermatology and skin biology and open up the dialogue between

Read more